Follow
Scott Eggener
Scott Eggener
Professor of Surgery (Urologic Oncology), University of Chicago
Verified email at surgery.bsd.uchicago.edu
Title
Cited by
Cited by
Year
MRI-targeted or standard biopsy for prostate-cancer diagnosis
V Kasivisvanathan, AS Rannikko, M Borghi, V Panebianco, LA Mynderse, ...
New England Journal of Medicine 378 (19), 1767-1777, 2018
27062018
Predicting 15-year prostate cancer specific mortality after radical prostatectomy
SE Eggener, PT Scardino, PC Walsh, M Han, AW Partin, BJ Trock, Z Feng, ...
The Journal of urology 185 (3), 869-875, 2011
7482011
Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies
SD Kundu, KA Roehl, SE Eggener, JAV Antenor, M Han, WJ Catalona
The Journal of urology 172 (6 Part 1), 2227-2231, 2004
6982004
Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group
CM Moore, V Kasivisvanathan, S Eggener, M Emberton, JJ Fütterer, ...
European urology 64 (4), 544-552, 2013
4602013
Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR
AB Rosenkrantz, S Verma, P Choyke, SC Eberhardt, SE Eggener, ...
The Journal of urology 196 (6), 1613-1618, 2016
4062016
Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities
SE Eggener, PT Scardino, PR Carroll, MJ Zelefsky, O Sartor, H Hricak, ...
The Journal of urology 178 (6), 2260-2267, 2007
4042007
The role of SPINK1 in ETS rearrangement-negative prostate cancers
SA Tomlins, DR Rhodes, J Yu, S Varambally, R Mehra, S Perner, ...
Cancer cell 13 (6), 519-528, 2008
4022008
Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance
RK Berglund, TA Masterson, KC Vora, SE Eggener, JA Eastham, ...
The Journal of urology 180 (5), 1964-1968, 2008
3352008
Management of small renal masses: American Society of Clinical Oncology clinical practice guideline
A Finelli, N Ismaila, B Bro, J Durack, S Eggener, A Evans, I Gill, D Graham, ...
J Clin Oncol 35 (6), 668-680, 2017
3282017
Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence
SE Eggener, O Yossepowitch, JA Pettus, ME Snyder, RJ Motzer, P Russo
Journal of clinical oncology 24 (19), 3101-3106, 2006
3242006
Positive surgical margins at partial nephrectomy: predictors and oncological outcomes
O Yossepowitch, RH Thompson, BC Leibovich, SE Eggener, JA Pettus, ...
The Journal of urology 179 (6), 2158-2163, 2008
3142008
New and established technology in focal ablation of the prostate: a systematic review
M Valerio, Y Cerantola, SE Eggener, H Lepor, TJ Polascik, A Villers, ...
European urology 71 (1), 17-34, 2017
3132017
Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score—a computer-aided …
Y Peng, Y Jiang, C Yang, JB Brown, T Antic, I Sethi, C Schmid-Tannwald, ...
Radiology 267 (3), 787-796, 2013
3092013
Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis
A Oto, C Yang, A Kayhan, M Tretiakova, T Antic, C Schmid-Tannwald, ...
American Journal of Roentgenology 197 (6), 1382-1390, 2011
3062011
Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods
O Yossepowitch, SE Eggener, FJ Bianco Jr, BS Carver, A Serio, ...
The Journal of urology 178 (2), 493-499, 2007
3022007
Increasing incidence of metastatic prostate cancer in the United States (2004–2013)
AB Weiner, RS Matulewicz, SE Eggener, EM Schaeffer
Prostate cancer and prostatic diseases 19 (4), 395-397, 2016
2912016
Nitric oxide contributes to the rise in forearm blood flow during mental stress in humans.
NM Dietz, JM Rivera, SE Eggener, RT Fix, DO Warner, MJ Joyner
The Journal of physiology 480 (2), 361-368, 1994
2811994
Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma
JC Brien, SF Shariat, MP Herman, CK Ng, DS Scherr, B Scoll, RG Uzzo, ...
The Journal of urology 184 (1), 69-73, 2010
2682010
Urinary cytology has a poor performance for predicting invasive or high‐grade upper‐tract urothelial carcinoma
J Messer, SF Shariat, JC Brien, MP Herman, CK Ng, DS Scherr, B Scoll, ...
BJU international 108 (5), 701-705, 2011
2662011
Focal therapy: patients, interventions, and outcomes—a report from a consensus meeting
IA Donaldson, R Alonzi, D Barratt, E Barret, V Berge, S Bott, D Bottomley, ...
European urology 67 (4), 771-777, 2015
2542015
The system can't perform the operation now. Try again later.
Articles 1–20